Efficacy and Safety of Olokizumab in a Phase III Trial of Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate - Placebo and Active Controlled Study

被引：0

作者：

Feist, Eugen ^{[1
]}

Fatenejad, Saeed ^{[2
]}

Grishin, Sergey ^{[3
]}

Korneva, Elena ^{[3
]}

Nasonov, Evgeniy ^{[4
]}

Rowinska-Osuch, Anna ^{[5
]}

Samsonov, Mikhail ^{[3
]}

Fleischmann, Roy ^{[6
,7
]}

机构：

[1] Helios Dept Rheumatol, Vogelsang Gommern, Germany

[2] SFC Med LLC, Charlotte, NC USA

[3] R Pharm, Moscow, Russia

[4] VA Nasonova Reseach Inst Rheumatol, Moscow, Russia

[5] MCM Polimed, Warsaw, Poland

[6] Metroplex Clin Res Ctr, Dallas, TX USA

[7] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1685

引用

页码：3508 / 3510

页数：3

共 50 条

[21] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
Mazurov, V.
Korolev, M.
Pristrom, A.
Kundzer, A.
Soroka, N.
Kastanayan, A.
Povarova, T.
Plaksina, T.
Antipova, O.
Kretchikova, D.
Smakotina, S.
Tciupa, O.
Puntus, E.
Raskina, T.
Shilova, L.
Kropotina, T.
Nesmeyanova, O.
Popova, T.
Vinogradova, I.
Linkova, I.
Plotnikova, A.
Pukhtinskaia, P.
Zinkina-Orikhan, A.
Eremeeva, A.
Lutckii, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 596 - 596
[22] EFFICACY AND SAFETY OF HLX01 COMBINED WITH METHOTREXATE IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD INADEQUATE RESPONSES TO METHOTREXATE: RESULTS OF A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY
Zeng, X.
Liu, J.
Liu, X.
Wu, L.
Liu, Y.
Liao, X.
Liu, H.
Hu, J.
Lu, X.
Chen, L.
Xu, J.
Jiang, Z.
Lu, F.
Wu, H.
Sun, L.
Wang, M.
Yu, X.
Wang, Q.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1122 - 1123
[23] Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Yoshiya Tanaka
Kazuteru Wada
Yoshinori Takahashi
Owen Hagino
Hubert van Hoogstraten
Neil M. H. Graham
Hideto Kameda
Arthritis Research & Therapy, 21
[24] Efficacy and Safety of Dapirolizumab Pegol in Patients with Moderately to Severely Active Systemic Lupus Erythematosus: A Randomized, Placebo-Controlled Study
Furie, Richard
Bruce, Ian
Doerner, Thomas
Gustavo Leon, Manuel
Leszczynski, Piotr
Urowitz, Murray
Haier, Birgit
Brittain, Claire
Liu, Jiajun
Barbey, Catherine
Stach, Christian
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[25] Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy
Li, Zhanguo
Zhang, Fengchun
Kay, Jonathan
Fei, Kaiyin
Han, Chenglong
Zhuang, Yanli
Wu, Zhong
Hsia, Elizabeth C.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1143 - 1156
[26] Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR
Mazurov, V. I.
Nasonov, E. L.
Lila, A. M.
Korolev, M. A.
Prystrom, A. M.
Kundzer, E. V.
Soroka, N. F.
Kastanayan, A. A.
Povarova, T. V.
Plaksina, T. V.
Antipova, O. V.
Krechikova, D. G.
Smakotina, S. A.
Tciupa, O. A.
Puntus, E. V.
Raskina, T. A.
Shilova, L. N.
Kropotina, T. V.
Nesmeyanova, O. B.
Popova, T. A.
Vinogradova, I. B.
Dokukina, E. A.
Plotnikova, A. V.
Pukhtinskaia, P. S.
Zinkina-Orikhan, A. V.
Linkova, Yu. N.
Eremeeva, A. V.
Lutckii, A. A.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2024, : 403 - 416
[27] Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
Smolen, J.
Landewe, R. B.
Mease, P.
Brzezicki, J.
Mason, D.
Luijtens, K.
van Vollenhoven, R. F.
Kavanaugh, A.
Schiff, M.
Burmester, G. R.
Strand, V.
Vencovsky, J.
van der Heijde, D.
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 797 - 804
[28] Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial
Yamamoto, Kazuhiko
Takeuchi, Tsutomu
Yamanaka, Hisashi
Ishiguro, Naoki
Tanaka, Yoshiya
Eguchi, Katsumi
Watanabe, Akira
Origasa, Hideki
Iwai, Koichi
Sakamaki, Yoshiharu
van der Heijde, Desiree
Miyasaka, Nobuyuki
Koike, Takao
MODERN RHEUMATOLOGY, 2014, 24 (04) : 552 - 560
[29] Janus kinase inhibitor baricitinib for rheumatoid arthritis: Randomized, double-blind, placebo- and active-controlled, phase 3 study evaluating the efficacy and safety of baricitinib in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy (RA-BEAM)
Alten R.
Nitschmann S.
Der Internist, 2017, 58 (12): : 1341 - 1344
[30] Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial
van Vollenhoven, Ronald F.
Keystone, Edward Clark
Strand, Vibeke
Pacheco-Tena, Cesar
Vencovsky, Jiri
Behrens, Frank
Racewicz, Arthur
Zipp, Daniela
Rharbaoui, Faiza
Wolter, Ralf
Knierim, Luise
Schmeidl, Rainer
Zhou, Xuefei
Aigner, Silke
Daelken, Benjamin
Wartenberg-Demand, Andrea
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) : 495 - 499

← 1 2 3 4 5 →